Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has raised
many questions about the management of patients with chronic obstructive pulmonary …

Rationale: Current guidelines recommend patients with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pneumonia receive empirical antibiotics for suspected …

Abstract The coronavirus disease 2019 (COVID-19) pandemic emerged in Wuhan, China, in
late 2109, and has rapidly spread around the world. Until May 25, 2020, there were 133,521 …

Abstract Background Coronavirus disease 2019 (COVID-19)–associated pulmonary
aspergillosis (CAPA) occurs in critically ill patients with COVID-19. Risks and outcomes …

Aspergillus co-infection in patients with severe coronavirus disease 2019 (COVID-19)
pneumonia, leading to acute respiratory distress syndrome, has recently been reported. To …

Enterobacterales represent the largest group of bacterial pathogens in humans and are
responsible for severe, deep-seated infections, often resulting in sepsis or death. They are …

The aim of this study was to evaluate diagnostic means, host factors, delay of occurrence,
and outcome of patients with COVID-19 pneumonia and fungal coinfections in the intensive …

Background: Bronchoscopy with bronchoalveolar lavage (BAL) during the SARS-CoV-2
(Severe Acute Respiratory Syndrome Coronavirus 2) pandemic should be reserved to a …

Background The COVID-19 pandemic is predicted to significantly affect patients with lung
cancer, owing to its rapid progression and high mortality. Studies on lung cancer diagnosis …